PF-Atlas › Clinical Trials › NCT05352165

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

standard long-term therapy · Not specified

Registry ID
NCT05352165
Phase
Not specified
Status
Unknown
Drug / intervention
standard long-term therapy
Sponsor
Shanghai Minimally Invasive Surgery Center
Start
2023-01-01

About this trial

standard long-term therapy is evaluated in NCT05352165, a idiopathic pulmonary fibrosis study sponsored by Shanghai Minimally Invasive Surgery Center. Current status: Unknown.

View NCT05352165 on ClinicalTrials.gov →

Medical disclaimer. This page summarizes public trial data for NCT05352165 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.